bioMerieux S.A. Stock
Your prediction
bioMerieux S.A. Stock
A loss of -1.010% shows a downward development for bioMerieux S.A..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for bioMerieux S.A. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of bioMerieux S.A. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of bioMerieux S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| bioMerieux S.A. | -1.010% | -0.053% | 1.672% | -18.328% | -14.474% | -3.274% | -12.973% |
| Sartorius Stedim Biotech S.A. | 1.030% | 6.642% | 2.339% | -12.979% | -16.308% | -41.995% | -48.408% |
| EssilorLuxottica SA | -0.840% | -5.180% | -16.310% | -23.118% | -24.991% | 27.159% | 50.351% |
| Dexcom Inc. | 0.170% | -0.017% | -1.784% | -10.558% | 1.832% | -45.264% | -20.517% |
Comments
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Show more
Ratings data for BMXMF provided by MarketBeat
